The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors

Cancer

Volumn 79, Issue 9, 1997, Pages 1804-1808

  Younes, Nidal ^a   Fulton, Noreen ^b   Tanaka, Reiko ^c   Wayne, Jeffrey ^a   Straus II, Francis H ^a   Kaplan, Edwin L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

adenocarcinoma of the colon; adenocarcinoma of the small intestine; carcinoid tumor of the small intestine; K 12 ras mutation

Indexed keywords

ASPARTIC ACID; DNA; GLYCINE;

ADULT; AGED; ARTICLE; CARCINOID; CARDIA CARCINOMA; COLON CARCINOMA; CONTROLLED STUDY; DUODENUM CARCINOMA; HUMAN; HUMAN TISSUE; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; PANCREAS CARCINOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOCARCINOMA; CARCINOID TUMOR; CODON; DUODENAL NEOPLASMS; GENES, RAS; HUMANS; INTESTINAL DISEASES; INTESTINAL NEOPLASMS; INTESTINE, SMALL; POINT MUTATION;

EID: 0031004361     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970501)79:9<1804::AID-CNCR24>3.0.CO;2-0     Document Type: Article

References (29)

1. Allen JI. Molecular biology of colon polyps and colon cancer. Semin Surg Oncol 1995;11:399-405.
2. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987;327:293-7.
3. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, et al. Allelotype of colorectal carcinomas. Science 1989;244:207-11.
4. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
5. Pastore C, D'Annibale A, Fregonese D, Conte C, Pignata G, Mora G. Malignant tumors of the small intestine: review of the literature and report of a clinical case. Minerva Chir 1993;48:1471-5.
6. Schark C, Fulton N, Jacoby RF, Westbrook CA, Straus FH II, Kaplan EL. N-ras 61 oncogene mutations in Hürthle cell tumors. Surgery 1990;108:994-1000.
7. Yashiro T, Hara H, Fulton NC, Obara T, Kaplan EL. Point mutations of ras genes in human adrenal cortical tumors: absence in adrenocortical hyperplasia. World J Surg 1994;18:455-61.
8. Ross RK, Hartnett NM, Bernstein L, Henderson BE. Epidemiology of adenocarcinoma of the small intestine: is bile a small bowel carcinogen? Br J Cancer 1991;63:143-5.
9. DiSario JA, Burt RW, Vargas H, McWhorter W. Small bowel cancer: epidemiological and clinical characteristics from population based registry. Am J Gastroenterol 1994;89:699-701.
10. Gabos S, Berkel J, Band P, Robson D, Whittaker H. Small bowel cancer in western Canada. Int J Epidemiol 1993; 22:198-206.
11. Zietels J, Naunheim K, Kaplan EL, Straus FH II. Carcinoid tumors: a 37 year experience. Arch Surg 1982;117:732-7.
12. Pretlow TP, Brasitus TA, Fulton NC, Cheyer C, Kaplan EL. K-ras mutations in putative preneoplastic lesion in human colon. J Nat Cancer Inst 1993;85:2004-7.
13. Jacoby RF, Llor X, Teng BB, Davidson NO, Brasitus TA. Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonie mucosa. J Clin Invest 1991;87:624-30.
14. Jacoby RF, Alexander RJ, Raicht RF, Brasitus TA. K-ras oncogene mutations in rat colon tumors induced by N-methyl-N-nitrosourea. Carcinogenesis 1992;13:45-49.
15. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987;327:298-303.
16. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal development. N Engl J Med 1988;319:525-32.
17. Sutter T, Arber N, Moss SF, Findling RI, Neugut AI, Weinstein IB, et al. Frequent K-ras mutalions in small bowel adenocarcinomas. Dig Dis Sci 1996;41:115-8.
18. Spandidos DA, Liloglou T, Arvantits D, Gourtsoyannis NC. Ras gene activation in human small intestinal tumors. Int J Oncol 1993;2:513-8.
19. Motojima K, Tsunoda T, Kanematsu T, Nagata Y, Urano T, Shiku H. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Ann Surg 1991;214:657-62.
20. Yashiro T, Fulton N, Hara H, Yasuda K, Montag A, Yashiro T, et al. Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors. Surgery 1993; 114:758-64.
21. Rodenhuis S, Slebos RJ. Clinical significance of ras oncogenes activation in human lung cancer. Cancer Res 1992; 52:2665-9.
22. Rodenhuis S, van de Wetering ML, Mooi WJ, Evers SG, Zandwijk N, van Bos JL. Mutational activation of the K-ras oncogene: a possible pathogenic factor in adenocarcinoma of the lung. N Engl J Med 1987;317:929-35.
23. Wagner SN, Müller R, Boehm J, Pütz B, Wünsch PH, Höfler H. Neuroendocrine neoplasms of the lung are not associated with point mutations at codon 12 of the Ki-ras gene. Virchows Arch B Cell Pathol 1993;63:325-9.
24. Capon DJ, Seeburg PH, McGrath JP, Hayflick JS, Edman U, Levinson AD, et al. Activation of Ki-ras 2 gene in human colon and lung carcinomas by two different point mutations. Nature 1983;304:507-13.
25. Shimizu K, Birnbaum D, Ruley MA, Fasano O, Suard Y, Edlund L, et al. Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. Nature 1983;304:497-500.
26. Yoshimoto K, Sano T, Katsuragi K, Iwahana H, Fukuda A, Kinoshita M, et al. Ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Jpn J Cancer Res 1992; 83:1057-62.
27. Okazaki M, Miya A, Tanaka N, Miki T, Yamamoto M, Motomura K, et al. Allele loss on chromosome 10 and point mutations of ras oncogenes are infrequent in tumors of MEN 2A. Henry Ford Hasp Med J 1989;32:112-5.
28. Moley JF, Brother MB, Wells SA, Spengler BA, Biedler JL, Brodeur GM. Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers. Cancer Res 1991;51:1596-9.
29. Karga HJ, Alexander JM, Hedley-White ET, Klibanski A, Jameson JL. Ras mutations in human pituitary tumors. J Clin Endocrinol Metab 1992;74:914-9.